Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) will give a presentation on the company's corporate overview at the BIO 12th Annual CEO and Investor Event. The company's CEO, Ronald Martell, will host their presentation at the event.
The company has been scheduled to deliver their presentation on at 1:00pm (EST) on February 9, 2010. The event is being held in New York City at the Waldorf Astoria Hotel. A webcast will be made available, both live and for replay, through the company's website.
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer.
Click here for more Business News
TransWorldNews.com, owned and operated by TransWorldNews, Inc. (parent company of social and business networking community site WooEB), is a global news and press release distribution outlet that implements a number of innovative applications, initiates online partnerships and collaborates with media outlets to effectively market news releases, business profiles, analyst reports, newsletters, audio interviews, blogs while providing a platform for advertising to increase awareness for client companies.
500 Bishop St. F9
Atlanta, Ga. 30318